Literature DB >> 16041526

Temporomandibular joint destruction in mucolipidosis type III necessitating gastrostomy insertion.

Zarzuela Zolkipli1, Lee Noimark, Maureen A Cleary, Cathy Owens, Ashok Vellodi.   

Abstract

UNLABELLED: Mucolipidosis III is a genetically heterogeneous lysosomal disorder characterised by progressive symptoms and signs, the commonest being skeletal pain due to bony destruction. We describe a patient who developed severe destruction of the temporomandibular joints leading to difficulties with speech and feeding, necessitating gastrostomy insertion.
CONCLUSION: Temporomandibular joint involvement has not been previously reported in mucolipidosis III.

Entities:  

Mesh：

Year:  2005        PMID： 16041526     DOI： 10.1007/s00431-005-1727-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  7 in total

1.  Orthopaedic manifestations of mucolipidosis III: an illustrative case.

Authors:  F S Haddad; R A Hill; A Vellodi
Journal:  J Pediatr Orthop B       Date:  2000-01       Impact factor: 1.041

2.  [Hurler's pseudo-polydystrophy].

Authors:  P Maroteaux; M Lamy
Journal:  Presse Med       Date:  1966-12-25       Impact factor: 1.228

3.  Bone densitometry in pediatric patients treated with pamidronate.

Authors:  Leslie E Grissom; Heidi H Kecskemethy; Steven J Bachrach; Charles McKay; H Theodore Harcke
Journal:  Pediatr Radiol       Date:  2005-01-18

4.  The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment.

Authors:  C Robinson; N Baker; J Noble; A King; G David; D Sillence; P Hofman; T Cundy
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

5.  Radiographic features of bisphosphonate therapy in pediatric patients.

Authors:  Leslie E Grissom; H Theodore Harcke
Journal:  Pediatr Radiol       Date:  2003-02-15

6.  Mucolipidosis II and III: different residual activity of beta-galactosidase in cultured fibroblasts.

Authors:  J G Leroy; J S O'Brien
Journal:  Clin Genet       Date:  1976-05       Impact factor: 4.438

7.  Orthopaedic management in four cases of mucolipidosis type III.

Authors:  C Hetherington; N J Harris; T W Smith
Journal:  J R Soc Med       Date:  1999-05       Impact factor: 5.344
  7 in total
  2 in total

1.  Enlarged follicles and temporomandibular joint abnormalities in mucolipidosis Type III.

Authors:  H Khalifa; H S Grubisa; L Lee; E W N Lam
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

2.  Mucolipidosis type III, a series of adult patients.

Authors:  Esmee Oussoren; David van Eerd; Elaine Murphy; Robin Lachmann; Jan C van der Meijden; Lies H Hoefsloot; Rob Verdijk; George J G Ruijter; Mario Maas; Carla E M Hollak; Janneke G Langendonk; Ans T van der Ploeg; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2018-04-27       Impact factor: 4.982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.